HQ: Temple City, California, United States

Fulgent Therapeutics Contact Information – Key Personnel, Emails & Support Lines

fulgentgenetics.com

About Fulgent Therapeutics Company

Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.

Fulgent Therapeutics Specialization

Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics

Fulgent Therapeutics General Information

HQ: Temple City, California, United States

Business Type: Public

Employees: 1001-5000

Rounds: Venture - Series Unknown

Founded Date: 2011

Company Type: For Profit

Stock Symbol: NASDAQ:FLGT

Operating Status: Active

Last Funding Type: Venture - Series Unknown

Phone Number: 626-350-0537

Last Investment Activity: Nov 7, 2022

Investments Activity: Nov 7, 2022 Oct 31, 2022 Oct 19, 2022

Fulgent Therapeutics Email Format

{first_letter_first_name}{last_name}@fulgentgenetics.com — 69.2% (example: ssmith@domain.com)

{first_name}{last_name}@fulgentgenetics.com — 30.8% (example: sarahsmith@domain.com)

Fulgent Therapeutics General Fulgent Therapeutics Emails

  • General Inquiries

    info@fulgentgenetics.com

  • Customer Service

    lacsupport@fulgentgenetics.com

  • Unclassified inbox

    insurance@fulgentgenetics.com

  • General Inquiries

    info@fulgent-therapeutics.com

  • Unclassified inbox

    preverification@fulgentgenetics.com

  • Unclassified inbox

    applyjob@fulgentgenetics.com

Contact details of 4 Fulgent Therapeutics executives

Natalie Prescott

General Counsel & Chief Privacy Officer
  • Work email

    n*******t@fulgentgenetics.com

Hanlin Gao

Lab Director and Chief Scientific Officer
  • Work email

    h**o@fulgentgenetics.com

Paul Kim

Chief Financial Officer
  • Work email

    p**m@fulgentgenetics.com

Mary Jane Abalos

VP Finance

Contact details of 10 Fulgent Therapeutics other employees

James Liu

Director of System Architecture,Enterprise Systems Architect
  • Work email

    j**u@fulgentgenetics.com

Lawrence Weiss

Job not specified
  • Work email

    l****s@fulgentgenetics.com

Ming Hsieh

Job not specified
  • Work email

    m*******h@fulgentgenetics.com

Alex Witterschein

Job not specified
  • Work email

    a**************n@fulgentgenetics.com

Erin Heaney

Job not specified
  • Work email

    e*****y@fulgentgenetics.com

Eric Chen

Job not specified
  • Work email

    e******n@fulgentgenetics.com

Rod Gervacio

CLS Lead
  • Work email

    r*******o@fulgentgenetics.com

Spencer Young

Solutions/Software Analyst/Scientist/Engineer
  • Work email

    s****g@fulgentgenetics.com

Benjamin Ramos

Talent Acquisition Specialist
  • Work email

    b****s@fulgentgenetics.com

Doreen Ng

VP, Operations & Compliance | General Manager (Houston)
  • Work email

    d******g@fulgentgenetics.com

Similar Companies like Fulgent Therapeutics

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: Minneapolis, Minnesota, United States

Medtronic

medtronic.com

Medtronic develops healthcare technology solutions for vario...

HQ: Minneapolis, Minnesota, United States

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Medical Devices Hospitals & Clinics

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 27, 2024

Founded Date: 1949

Number of Exits: 28

Company Type: For Profit

Stock Symbol: NYSE:MDT

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital


Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.